Representative Rob Bresnahan, Jr. of Pennsylvania recently made headlines—not for legislation, but for investing between ...

While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Enterprise Products Partners LP operates as holding company, which engages in the production and trade of natural gas and petrochemicals. It operates through the following segments: NGL Pipelines ...

Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

A portfolio composed of Ultra SWAN stocks can deliver strong returns for investors. Read about six stock selections that can ...

Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

Better than expected commodity performance tends to make the bottom line look better when prices stay high, even though that ...

Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...

Stock markets mostly rose on Monday as worries about fresh US tariffs pencilled in for next week were tempered by hopes that ...